271 studies found for:    Open Studies | "Uterine Cervical Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting Irreversible Electroporation(IRE) For Uterine Cervical Neoplasms
Condition: Uterine Cervical Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
2 Recruiting FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer
Conditions: Cervical Cancer;   Uterine Cervical Cancer;   Uterine Cervical Neoplasms
Interventions: Device: FDG-PET/MR;   Device: FDG-PET/CT
3 Unknown  Economic Evaluation of Three Populational Screening Strategies for Cervical Cancer
Condition: Uterine Cervical Neoplasms
Intervention: Other: Different alternatives to improve the coverage of the populational screening programmes of cervical cancer
4 Recruiting MR Metabolic Biomarkers for Cervical Cancer
Condition: Uterine Cervical Neoplasms
Intervention:
5 Recruiting MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Cervical Undifferentiated Carcinoma;   Recurrent Cervical Carcinoma;   Stage IB Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer
Interventions: Procedure: Computed Tomography;   Procedure: Diffusion Weighted Imaging;   Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging;   Radiation: Fludeoxyglucose F-18;   Procedure: Magnetic Resonance Spectroscopic Imaging;   Procedure: Positron Emission Tomography
6 Recruiting Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer
Conditions: Recurrent Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Intervention: Drug: eribulin mesylate
7 Recruiting Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB2 Cervical Cancer;   Stage II Vaginal Cancer;   Stage IIA1 Cervical Cancer;   Stage IIA2 Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Vaginal Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Vaginal Adenocarcinoma;   Vaginal Adenosquamous Carcinoma;   Vaginal Squamous Cell Carcinoma
Interventions: Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: Internal Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Drug: Triapine
8 Recruiting AZD1775, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer
Conditions: Stage IB Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer
Interventions: Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: Internal Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Radiation: Pulsed-Dose Rate Brachytherapy;   Drug: WEE1 Inhibitor MK-1775
9 Recruiting Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Chemotherapeutic Agent Toxicity;   Cognitive Side Effects of Cancer Therapy;   Psychological Impact of Cancer;   Radiation Toxicity;   Sexual Dysfunction and Infertility;   Stage IB Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer
Interventions: Drug: Carboplatin;   Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: Internal Radiation Therapy;   Drug: Paclitaxel;   Other: Quality-of-Life Assessment
10 Recruiting Chemoradiation Therapy and Ipilimumab in Treating Patients With Locally Advanced Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer
Interventions: Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: Internal Radiation Therapy;   Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis
11 Recruiting ADXS11-001 High Dose HPV+ Cervical Cancer
Conditions: Effects of Immunotherapy;   Metastatic/Recurrent Cervical Cancer;   Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Intervention: Biological: ADXS11-001
12 Recruiting Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IA Cervical Cancer;   Stage IB Cervical Cancer;   Stage IIA Cervical Cancer
Interventions: Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
13 Recruiting HPV-test, Cervical Cancer and Follow-up
Conditions: Human Papilloma Virus;   Uterine Cervical Neoplasms;   Recurrence
Intervention: Procedure: Human Papilloma Virus test from the vaginal vault
14 Recruiting Repetitive Functional Imaging in Locally Advanced Cervical Cancer
Condition: Uterine Cervical Neoplasms
Intervention:
15 Not yet recruiting The Effect of Postoperative Therapy on the Quality of Life of Patients With Early Cervical Cancer Research
Condition: Uterine Cervical Neoplasms
Intervention:
16 Not yet recruiting Phase II Study of Pazopanib and Topotecan in Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: Pazopanib;   Drug: Topotecan;   Behavioral: Phone Call
17 Not yet recruiting The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial
Conditions: Uterine Cervical Neoplasms;   Squamous Cell Carcinoma;   Adenocarcinoma;   Carcinoma, Adenosquamous
Interventions: Drug: Metformin;   Drug: Cisplatin;   Drug: FAZA
18 Unknown  Hypoxia Imaging With 18F FAZA. Prognostic Impact in Cervical Cancer
Condition: Uterine Cervical Neoplasms
Intervention: Drug: 18F Fluoroazomycin Arabinoside (FAZA)
19 Not yet recruiting A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer
Condition: Uterine Cervical Neoplasms
Interventions: Biological: INO-3112 vaccine;   Radiation: Radiotherapy (Extrernal beam radiotherapy + brachytherapy);   Drug: Cisplatin chemotherapy
20 Recruiting Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Radiotherapy;   Drug: Cisplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years